Therapy - Verotoxin 1

Immunization with Recombinant Verotoxin 1 Simulates Anticancer Proteins

Published in Vaccine Weekly, August 14th, 1995

Researchers finally pinpoint the antineoplastic bacteriocin preparation in Escherichia coli that has eluded identification for over 20 years.

Bacterial proteins, called bacteriocins, are produced to prevent the growth of competing microorganisms within a particular biological niche. A preparation of a bacteriocine from the HSC₁₀ strain of E. coli has shown antineoplastic activity in vitro against a variety of human tumor cell lines and also in vivo against Mycosis fungoides skin tumors in humans in many studies.

This preparation of partially purified bacteriocin [or anticancer proteins (ACP)] has also been shown to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-08-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry